Antimullerian hormone and inhibin B are hormone measures of ovarian function in late reproductive-aged breast cancer survivors (Q33624886)

28 July 2017

title

Antimullerian hormone and inhibin B are hormone measures of ovarian function in late reproductive-aged breast cancer survivors (English)

1 reference

28 July 2017

7

Ellen W Freeman

1 reference

28 July 2017

H Irene Su

1

1 reference

28 July 2017

Mary D Sammel

2

1 reference

28 July 2017

Jamie Green

3

1 reference

28 July 2017

Luke Velders

4

1 reference

28 July 2017

Corrie Stankiewicz

5

1 reference

28 July 2017

Jennifer Matro

6

1 reference

28 July 2017

Clarisa R Gracia

8

1 reference

28 July 2017

Angela DeMichele

9

1 reference

28 July 2017

language of work or name

English

0 references

publication date

1 February 2010

1 reference

28 July 2017

1 reference

28 July 2017

volume

116

1 reference

28 July 2017

issue

3

1 reference

28 July 2017

page(s)

592-599

1 reference

Rational management of endocrine resistance in breast cancer: a comprehensive review of estrogen receptor biology, treatment options, and future directions.

28 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2815049

Anti-mullerian hormone and inhibin B in the definition of ovarian aging and the menopause transition

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2815049

Relationship of serum antimüllerian hormone concentration to age at menopause

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2815049

A pilot study of predictive markers of chemotherapy-related amenorrhea among premenopausal women with early stage breast cancer

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2815049

21 June 2018

Cancer statistics, 2008

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2815049

A review of hormonal changes during the menopausal transition: focus on findings from the Melbourne Women's Midlife Health Project.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2815049

Predictors of ovarian reserve in young women with breast cancer

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2815049

Amenorrhea in premenopausal women after adjuvant chemotherapy for breast cancer.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2815049

A systematic review of tests predicting ovarian reserve and IVF outcome

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2815049

Fertility in female cancer survivors: pathophysiology, preservation and the role of ovarian reserve testing

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2815049

Ovarian function in premenopausal women treated with adjuvant chemotherapy for breast cancer

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2815049

Early menopause in long-term survivors of cancer during adolescence

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2815049

Pituitary-ovarian function in breast cancer patients on adjuvant chemoimmunotherapy

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2815049

Executive summary: Stages of Reproductive Aging Workshop (STRAW).

21 June 2018

1 reference

Crossref

https://api.crossref.org/works/10.1002%2FCNCR.24746

Association of anti-mullerian hormone levels with obesity in late reproductive-age women.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2815049

Defining menopause status: creation of a new definition to identify the early changes of the menopausal transition

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2815049

Follicular phase hormone levels and menstrual bleeding status in the approach to menopause

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2815049

High reproducibility of serum anti-Mullerian hormone measurements suggests a multi-staged follicular secretion and strengthens its role in the assessment of ovarian follicular status.

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2815049

Anti-müllerian hormone is a promising predictor for the occurrence of the menopausal transition

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2815049

Estrogenic effects of toremifene and tamoxifen in postmenopausal breast cancer patients

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2815049

Reduced Ovarian Function in Long-Term Survivors of Radiation- and Chemotherapy-Treated Childhood Cancer

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2815049

Depletion of ovarian reserve in young women after treatment for cancer in childhood: detection by anti-Müllerian hormone, inhibin B and ovarian ultrasound

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2815049

Antimüllerian hormone serum levels: a putative marker for ovarian aging

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2815049

Effects of adjuvant chemohormonal therapy on the ovarian and adrenal function of breast cancer patients

30 October 2018

1 reference

12 December 2020

Immediate and long-term toxicity of adjuvant chemotherapy regimens containing doxorubicin in trials at M.D. Anderson Hospital and Tumor Institute

1 reference

12 December 2020

Endocrine effects of adjuvant chemotherapy and long-term tamoxifen administration on node-positive patients with breast cancer

1 reference

12 December 2020

Serum inhibin during lactation: relation to the gonadotrophins and gonadal steroids

1 reference

12 December 2020

Adjuvant aromatase inhibitors for early breast cancer after chemotherapy-induced amenorrhoea: caution and suggested guidelines

1 reference

12 December 2020

The effects of chemotherapy and long-term gonadotrophin suppression on the ovarian reserve in premenopausal women with breast cancer

1 reference

12 December 2020

Risk of menopause during the first year after breast cancer diagnosis

1 reference

12 December 2020

Prognostic effect of amenorrhoea and elevated serum gonadotropin levels induced by adjuvant chemotherapy in premenopausal node-positive breast cancer patients

1 reference

12 December 2020

Identifiers

DOI

10.1002/CNCR.24746

1 reference

28 July 2017

1 reference

28 July 2017

1 reference